Why is Shree Ganesh Bio falling/rising?

As of 16-Sep, Shree Ganesh Biotech India Ltd is currently priced at 0.79, with no change in price (0.00%). The stock has shown a performance today that outperformed its sector by 0.51%. It is trading higher than its 20-day moving averages but lower than its 5-day, 50-day, 100-day, and 200-day moving averages. Despite a recent increase in delivery volume by 168.58% against the 5-day average, the stock has experienced significant declines over the longer term, with a year-to-date return of -24.04% and a one-year return of -29.46%. The company is facing challenges, including operating losses and a weak ability to service its debt, which contributes to its classification as a strong sell. In the broader market context, the stock's short-term performance of +1.28% over the past month is underwhelming compared to the Sensex's +2.21% return in the same period. While the stock has outperformed its sector today, its long-term performance remains concerning, especially with a negative EBITDA and a significant drop in profits over the past year. The overall market has shown resilience, with the Sensex gaining +5.43% year-to-date, contrasting sharply with Shree Ganesh Biotech's struggles.